Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis
- PMID: 32461330
- PMCID: PMC7295861
- DOI: 10.1136/heartjnl-2020-317062
Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis
Abstract
Background: Coronavirus disease 2019 (COVID-19) has produced a significant health burden worldwide, especially in patients with cardiovascular comorbidities. The aim of this systematic review and meta-analysis was to assess the impact of underlying cardiovascular comorbidities and acute cardiac injury on in-hospital mortality risk.
Methods: PubMed, Embase and Web of Science were searched for publications that reported the relationship of underlying cardiovascular disease (CVD), hypertension and myocardial injury with in-hospital fatal outcomes in patients with COVID-19. The ORs were extracted and pooled. Subgroup and sensitivity analyses were performed to explore the potential sources of heterogeneity.
Results: A total of 10 studies were enrolled in this meta-analysis, including eight studies for CVD, seven for hypertension and eight for acute cardiac injury. The presence of CVD and hypertension was associated with higher odds of in-hospital mortality (unadjusted OR 4.85, 95% CI 3.07 to 7.70; I2=29%; unadjusted OR 3.67, 95% CI 2.31 to 5.83; I2=57%, respectively). Acute cardiac injury was also associated with a higher unadjusted odds of 21.15 (95% CI 10.19 to 43.94; I2=71%).
Conclusion: COVID-19 patients with underlying cardiovascular comorbidities, including CVD and hypertension, may face a greater risk of fatal outcomes. Acute cardiac injury may act as a marker of mortality risk. Given the unadjusted results of our meta-analysis, future research are warranted.
Keywords: cardiac risk factors and prevention; epidemiology; global health; meta-analysis.
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures




Similar articles
-
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017. JAMA Cardiol. 2020. PMID: 32219356 Free PMC article.
-
Getting to the heart of the matter of COVID-19.Heart. 2020 Aug;106(15):1117-1118. doi: 10.1136/heartjnl-2020-317118. Epub 2020 May 27. Heart. 2020. PMID: 32461328 No abstract available.
-
Myocardial Injury Biomarkers and Cardiac Complications Associated with Mortality in Patients with COVID-19.Arq Bras Cardiol. 2020 Aug 28;115(2):273-277. doi: 10.36660/abc.20200372. Arq Bras Cardiol. 2020. PMID: 32876196 Free PMC article. English, Portuguese.
-
Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis.J Glob Health. 2020 Dec;10(2):020503. doi: 10.7189/jogh.10.020503. J Glob Health. 2020. PMID: 33110586 Free PMC article.
-
Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.Eur J Clin Invest. 2020 Oct;50(10):e13362. doi: 10.1111/eci.13362. Epub 2020 Aug 27. Eur J Clin Invest. 2020. PMID: 32726868
Cited by
-
Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss.Geroscience. 2020 Dec;42(6):1547-1578. doi: 10.1007/s11357-020-00272-3. Epub 2020 Oct 1. Geroscience. 2020. PMID: 33001410 Free PMC article. Review.
-
Analysis of Scientific Publications During the Early Phase of the COVID-19 Pandemic: Topic Modeling Study.J Med Internet Res. 2020 Nov 10;22(11):e21559. doi: 10.2196/21559. J Med Internet Res. 2020. PMID: 33031049 Free PMC article.
-
Inflammatory biomarkers and cardiac injury in COVID-19 patients.Front Public Health. 2022 Nov 24;10:1024535. doi: 10.3389/fpubh.2022.1024535. eCollection 2022. Front Public Health. 2022. PMID: 36505005 Free PMC article.
-
Comprehensive Review of Cardiovascular Complications of Coronavirus Disease 2019 and Beneficial Treatments.Cardiol Rev. 2022 May-Jun 01;30(3):145-157. doi: 10.1097/CRD.0000000000000422. Cardiol Rev. 2022. PMID: 35384908 Free PMC article. Review.
-
Investigating the Potential for Ultraviolet Light to Modulate Morbidity and Mortality From COVID-19: A Narrative Review and Update.Front Cardiovasc Med. 2020 Dec 23;7:616527. doi: 10.3389/fcvm.2020.616527. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33426009 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources